Citadel Advisors’s Elevance Health ELV Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $35.5M | Sell |
121,100
-116,200
| -49% | -$38.2M | 0.01% | 1692 |
|
|
2025
Q4 | $83.2M | Sell |
237,300
-273,000
| -53% | -$92.3M | 0.01% | 987 |
|
|
2025
Q3 | $165M | Buy |
510,300
+268,500
| +111% | +$83.5M | 0.03% | 567 |
|
|
2025
Q2 | $94.1M | Buy |
241,800
+87,100
| +56% | +$35M | 0.02% | 808 |
|
|
2025
Q1 | $67.3M | Sell |
154,700
-93,300
| -38% | -$37.5M | 0.01% | 932 |
|
|
2024
Q4 | $91.5M | Buy |
248,000
+162,400
| +190% | +$68M | 0.02% | 783 |
|
|
2024
Q3 | $44.5M | Sell |
85,600
-85,700
| -50% | -$45.8M | 0.01% | 1326 |
|
|
2024
Q2 | $92.8M | Hold |
171,300
| – | – | 0.02% | 730 |
|
|
2024
Q1 | $88.8M | Sell |
171,300
-104,600
| -38% | -$52M | 0.02% | 778 |
|
|
2023
Q4 | $130M | Buy |
275,900
+91,400
| +50% | +$42.3M | 0.03% | 541 |
|
|
2023
Q3 | $80.3M | Buy |
184,500
+16,000
| +9% | +$7.26M | 0.02% | 754 |
|
|
2023
Q2 | $74.9M | Sell |
168,500
-8,700
| -5% | -$4.01M | 0.02% | 787 |
|
|
2023
Q1 | $81.5M | Sell |
177,200
-104,800
| -37% | -$49.9M | 0.02% | 736 |
|
|
2022
Q4 | $145M | Sell |
282,000
-128,700
| -31% | -$65.3M | 0.03% | 475 |
|
|
2022
Q3 | $187M | Sell |
410,700
-28,100
| -6% | -$13.4M | 0.04% | 328 |
|
|
2022
Q2 | $212M | Buy |
438,800
+273,100
| +165% | +$135M | 0.05% | 263 |
|
|
2022
Q1 | $81.4M | Sell |
165,700
-4,100
| -2% | -$1.87M | 0.02% | 769 |
|
|
2021
Q4 | $78.7M | Sell |
169,800
-15,800
| -9% | -$6.65M | 0.02% | 827 |
|
|
2021
Q3 | $69.2M | Sell |
185,600
-20,000
| -10% | -$7.6M | 0.01% | 892 |
|
|
2021
Q2 | $78.5M | Sell |
205,600
-40,300
| -16% | -$15.4M | 0.02% | 813 |
|
|
2021
Q1 | $88.3M | Buy |
245,900
+3,700
| +2% | +$1.19M | 0.02% | 650 |
|
|
2020
Q4 | $77.8M | Sell |
242,200
-43,800
| -15% | -$13.4M | 0.02% | 684 |
|
|
2020
Q3 | $76.8M | Sell |
286,000
-18,300
| -6% | -$4.92M | 0.02% | 604 |
|
|
2020
Q2 | $80M | Buy |
304,300
+44,700
| +17% | +$11.9M | 0.03% | 515 |
|
|
2020
Q1 | $58.9M | Buy |
259,600
+12,200
| +5% | +$3.32M | 0.03% | 568 |
|
|
2019
Q4 | $74.7M | Sell |
247,400
-26,900
| -10% | -$7.4M | 0.03% | 542 |
|
|
2019
Q3 | $65.9M | Buy |
274,300
+5,400
| +2% | +$1.48M | 0.03% | 599 |
|
|
2019
Q2 | $75.9M | Buy |
268,900
+140,800
| +110% | +$38.5M | 0.03% | 512 |
|
|
2019
Q1 | $36.8M | Buy |
128,100
+65,300
| +104% | +$18.9M | 0.02% | 871 |
|
|
2018
Q4 | $16.5M | Sell |
62,800
-38,600
| -38% | -$10.6M | 0.01% | 1392 |
|
|
2018
Q3 | $27.8M | Buy |
101,400
+32,100
| +46% | +$8.33M | 0.01% | 1134 |
|
|
2018
Q2 | $16.5M | Buy |
69,300
+6,300
| +10% | +$1.46M | 0.01% | 1475 |
|
|
2018
Q1 | $13.8M | Sell |
63,000
-10,100
| -14% | -$2.37M | 0.01% | 1435 |
|
|
2017
Q4 | $16.4M | Buy |
73,100
+10,300
| +16% | +$2.19M | 0.01% | 1286 |
|
|
2017
Q3 | $11.9M | Buy |
62,800
+30,000
| +91% | +$5.71M | 0.01% | 1449 |
|
|
2017
Q2 | $6.17M | Sell |
32,800
-21,500
| -40% | -$3.86M | 0.01% | 1899 |
|
|
2017
Q1 | $8.98M | Sell |
54,300
-10,300
| -16% | -$1.64M | 0.01% | 1520 |
|
|
2016
Q4 | $9.29M | Buy |
64,600
+1,500
| +2% | +$201K | 0.01% | 1422 |
|
|
2016
Q3 | $7.91M | Buy |
63,100
+14,600
| +30% | +$1.89M | 0.01% | 1573 |
|
|
2016
Q2 | $6.37M | Sell |
48,500
-7,200
| -13% | -$985K | 0.01% | 1625 |
|
|
2016
Q1 | $7.74M | Buy |
55,700
+3,700
| +7% | +$494K | 0.01% | 1393 |
|
|
2015
Q4 | $7.25M | Sell |
52,000
-34,600
| -40% | -$4.77M | 0.01% | 1514 |
|
|
2015
Q3 | $12.1M | Sell |
86,600
-11,200
| -11% | -$1.68M | 0.01% | 1217 |
|
|
2015
Q2 | $16.1M | Buy |
97,800
+22,900
| +31% | +$3.66M | 0.01% | 1157 |
|
|
2015
Q1 | $11.6M | Sell |
74,900
-39,500
| -35% | -$5.62M | 0.01% | 1337 |
|
|
2014
Q4 | $14.4M | Sell |
114,400
-56,500
| -33% | -$6.98M | 0.01% | 1151 |
|
|
2014
Q3 | $20.4M | Buy |
170,900
+17,900
| +12% | +$2.05M | 0.02% | 890 |
|
|
2014
Q2 | $16.5M | Sell |
153,000
-20,300
| -12% | -$2.09M | 0.02% | 924 |
|
|
2014
Q1 | $17.3M | Sell |
173,300
-3,000
| -2% | -$271K | 0.02% | 907 |
|
|
2013
Q4 | $16.3M | Buy |
176,300
+57,000
| +48% | +$5.06M | 0.02% | 920 |
|
|
2013
Q3 | $9.97M | Buy |
119,300
+29,100
| +32% | +$2.49M | 0.02% | 1104 |
|
|
2013
Q2 | $7.38M | Buy |
+90,200
| New | +$6.75M | 0.01% | 1257 |
|
Other funds holding ELV
VCM
VPM
Citadel Advisors's ELV Position: Q1 2026 in Review
Citadel Advisors reduced its Elevance Health (ELV) stake by 6.3% in Q1 2026, selling an estimated $34.8M and leaving 1,562,219 shares worth $457M. The position accounts for 0.07% of the portfolio, ranked #199.
Citadel Advisors first reported a position in ELV in Q2 2013 and has held it in 49 quarters since. The position peaked at $585M in Q4 2025. 1,462 funds tracked by Wall St. Rank hold ELV as of Q1 2026.
- Citadel Advisors held 1,562,219 shares of Elevance Health worth $457M as of Q1 2026.
- Citadel Advisors sold 105,850 Elevance Health shares in Q1 2026, an estimated $34.8M.
- Elevance Health made up 0.07% of Citadel Advisors's portfolio in Q1 2026, its #199 holding.
- Citadel Advisors first reported a position in Elevance Health in Q2 2013 and has held it in 49 quarters since.
- Citadel Advisors's Elevance Health position peaked at $585M in Q4 2025.
- 1,462 funds tracked by Wall St. Rank held Elevance Health as of Q1 2026.
Based on Citadel Advisors's 13F filing for Q1 2026, filed 15 May 2026.